Work

Phase 1 Study of Talabostat and Rituximab in Patients with Indolent Non-Hodgkin’s Lymphoma with Primary Resistance to or Progression Following Rituximab.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.1403.1403

Authors: Ayad Al-Katib, David D. Hurd, Robert Raju, Joe Stephenson, Francis Giles, Eric Haltom, Margaret J. Uprichard

Institutions: Wake Forest University Health Sciences, Wake Forest University, Prisma Health, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2535758366

FWCI: 0.228

Cites:

Cited by: 8

Related to: 10